Standard

COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza. / Ilyicheva, T. N.; Netesov, S. V.; Gureyev, V. N.

In: Molecular Genetics, Microbiology and Virology, Vol. 37, No. 1, 1, 03.2022, p. 1-9.

Research output: Contribution to journalReview articlepeer-review

Harvard

APA

Vancouver

Author

BibTeX

@article{fd033c8c15e3452ca58760b756b55ed0,
title = "COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza",
abstract = "The paper briefly reviews pathogens causing acute respiratory viral infections (ARVIs), including influenza viruses; coronaviruses, including SARS-CoV-2; parainfluenza viruses, adenoviruses, pneumoviruses, and specifically respiratory syncytial virus and metapneumoviruses, enteroviruses, rhinoviruses, and bocaviruses. This review presents modern data on the structure and replication of viruses, epidemiology, and immunopathogenesis of diseases and on diagnostics, preventive vaccination, and antiviral drugs for the treatment of ARVIs. Special attention is paid to the SARS-CoV-2 virus caused COVID-19 pandemic with analyses of similarities and differences between COVID-19 and other ARVIs, first of all, influenza virus. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.",
keywords = "acute respiratory viral infection, acute respiratory viral infection prophylaxis, COVID-19, immunopathogenesis, influenza, respiratory viruses, SARS-CoV-2, viral replication",
author = "Ilyicheva, {T. N.} and Netesov, {S. V.} and Gureyev, {V. N.}",
note = "Funding Information: The work was supported by the Russian Foundation for Basic Research, project no. 20-115-50029 and a state order to Novosibirsk State University, no. FSUS-2020-0035. Publisher Copyright: {\textcopyright} 2022, Allerton Press, Inc.",
year = "2022",
month = mar,
doi = "10.3103/S0891416822010025",
language = "English",
volume = "37",
pages = "1--9",
journal = "Molecular Genetics, Microbiology and Virology",
issn = "0891-4168",
publisher = "Allerton Press Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza

AU - Ilyicheva, T. N.

AU - Netesov, S. V.

AU - Gureyev, V. N.

N1 - Funding Information: The work was supported by the Russian Foundation for Basic Research, project no. 20-115-50029 and a state order to Novosibirsk State University, no. FSUS-2020-0035. Publisher Copyright: © 2022, Allerton Press, Inc.

PY - 2022/3

Y1 - 2022/3

N2 - The paper briefly reviews pathogens causing acute respiratory viral infections (ARVIs), including influenza viruses; coronaviruses, including SARS-CoV-2; parainfluenza viruses, adenoviruses, pneumoviruses, and specifically respiratory syncytial virus and metapneumoviruses, enteroviruses, rhinoviruses, and bocaviruses. This review presents modern data on the structure and replication of viruses, epidemiology, and immunopathogenesis of diseases and on diagnostics, preventive vaccination, and antiviral drugs for the treatment of ARVIs. Special attention is paid to the SARS-CoV-2 virus caused COVID-19 pandemic with analyses of similarities and differences between COVID-19 and other ARVIs, first of all, influenza virus. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.

AB - The paper briefly reviews pathogens causing acute respiratory viral infections (ARVIs), including influenza viruses; coronaviruses, including SARS-CoV-2; parainfluenza viruses, adenoviruses, pneumoviruses, and specifically respiratory syncytial virus and metapneumoviruses, enteroviruses, rhinoviruses, and bocaviruses. This review presents modern data on the structure and replication of viruses, epidemiology, and immunopathogenesis of diseases and on diagnostics, preventive vaccination, and antiviral drugs for the treatment of ARVIs. Special attention is paid to the SARS-CoV-2 virus caused COVID-19 pandemic with analyses of similarities and differences between COVID-19 and other ARVIs, first of all, influenza virus. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.

KW - acute respiratory viral infection

KW - acute respiratory viral infection prophylaxis

KW - COVID-19

KW - immunopathogenesis

KW - influenza

KW - respiratory viruses

KW - SARS-CoV-2

KW - viral replication

UR - http://www.scopus.com/inward/record.url?scp=85135272537&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/95b5e0d7-9774-30d1-81b8-4f6bf386beb8/

U2 - 10.3103/S0891416822010025

DO - 10.3103/S0891416822010025

M3 - Review article

C2 - 35936505

AN - SCOPUS:85135272537

VL - 37

SP - 1

EP - 9

JO - Molecular Genetics, Microbiology and Virology

JF - Molecular Genetics, Microbiology and Virology

SN - 0891-4168

IS - 1

M1 - 1

ER -

ID: 36766362